vs

Side-by-side financial comparison of REGAL REXNORD CORP (RRX) and STIFEL FINANCIAL CORP (SF). Click either name above to swap in a different company.

REGAL REXNORD CORP is the larger business by last-quarter revenue ($1.5B vs $1.1B, roughly 1.4× STIFEL FINANCIAL CORP). STIFEL FINANCIAL CORP runs the higher net margin — 23.5% vs 4.2%, a 19.3% gap on every dollar of revenue. On growth, STIFEL FINANCIAL CORP posted the faster year-over-year revenue change (23.0% vs 4.3%). STIFEL FINANCIAL CORP produced more free cash flow last quarter ($369.0M vs $140.6M). Over the past eight quarters, STIFEL FINANCIAL CORP's revenue compounded faster (21.1% CAGR vs -0.8%).

Regal Rexnord Corporation is a manufacturer of electric motors and power transmission components based in Milwaukee, Wisconsin. The company has manufacturing, sales, and service facilities throughout the United States, Canada, Mexico, Europe, and Asia, with about 29,000 employees.

Stifel Financial Corp. is an American multinational independent investment bank and financial services company created under the Stifel name in July 1983 and listed on the New York Stock Exchange on November 24, 1986. Its predecessor company was founded in 1890 as the Altheimer and Rawlings Investment Company and is headquartered in downtown St. Louis, Missouri.

RRX vs SF — Head-to-Head

Bigger by revenue
RRX
RRX
1.4× larger
RRX
$1.5B
$1.1B
SF
Growing faster (revenue YoY)
SF
SF
+18.8% gap
SF
23.0%
4.3%
RRX
Higher net margin
SF
SF
19.3% more per $
SF
23.5%
4.2%
RRX
More free cash flow
SF
SF
$228.4M more FCF
SF
$369.0M
$140.6M
RRX
Faster 2-yr revenue CAGR
SF
SF
Annualised
SF
21.1%
-0.8%
RRX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
RRX
RRX
SF
SF
Revenue
$1.5B
$1.1B
Net Profit
$63.4M
$264.4M
Gross Margin
37.5%
Operating Margin
10.8%
27.3%
Net Margin
4.2%
23.5%
Revenue YoY
4.3%
23.0%
Net Profit YoY
53.9%
8.3%
EPS (diluted)
$0.95
$2.30

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RRX
RRX
SF
SF
Q4 25
$1.5B
$1.1B
Q3 25
$1.5B
$962.6M
Q2 25
$1.5B
$838.9M
Q1 25
$1.4B
$842.5M
Q4 24
$1.5B
$916.0M
Q3 24
$1.5B
$810.9M
Q2 24
$1.5B
$798.9M
Q1 24
$1.5B
$768.1M
Net Profit
RRX
RRX
SF
SF
Q4 25
$63.4M
$264.4M
Q3 25
$79.6M
$211.4M
Q2 25
$79.2M
$155.1M
Q1 25
$57.3M
$53.0M
Q4 24
$41.2M
$244.0M
Q3 24
$72.7M
$158.5M
Q2 24
$62.5M
$165.3M
Q1 24
$19.8M
$163.6M
Gross Margin
RRX
RRX
SF
SF
Q4 25
37.5%
Q3 25
37.0%
Q2 25
37.7%
Q1 25
37.2%
Q4 24
34.9%
Q3 24
37.7%
Q2 24
36.9%
Q1 24
35.7%
Operating Margin
RRX
RRX
SF
SF
Q4 25
10.8%
27.3%
Q3 25
11.6%
29.7%
Q2 25
12.2%
25.5%
Q1 25
11.3%
7.5%
Q4 24
8.8%
29.1%
Q3 24
11.8%
26.7%
Q2 24
12.5%
28.4%
Q1 24
8.7%
28.5%
Net Margin
RRX
RRX
SF
SF
Q4 25
4.2%
23.5%
Q3 25
5.3%
22.0%
Q2 25
5.3%
18.5%
Q1 25
4.0%
6.3%
Q4 24
2.8%
26.6%
Q3 24
4.9%
19.5%
Q2 24
4.0%
20.7%
Q1 24
1.3%
21.3%
EPS (diluted)
RRX
RRX
SF
SF
Q4 25
$0.95
$2.30
Q3 25
$1.20
$1.84
Q2 25
$1.19
$1.34
Q1 25
$0.86
$0.39
Q4 24
$0.61
$2.10
Q3 24
$1.09
$1.34
Q2 24
$0.94
$1.41
Q1 24
$0.30
$1.40

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RRX
RRX
SF
SF
Cash + ST InvestmentsLiquidity on hand
$521.7M
$2.3B
Total DebtLower is stronger
$4.8B
$617.4M
Stockholders' EquityBook value
$6.8B
$6.0B
Total Assets
$13.9B
$41.3B
Debt / EquityLower = less leverage
0.70×
0.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RRX
RRX
SF
SF
Q4 25
$521.7M
$2.3B
Q3 25
$400.0M
$3.2B
Q2 25
$320.1M
$1.9B
Q1 25
$305.3M
$2.7B
Q4 24
$393.5M
$2.6B
Q3 24
$458.6M
$1.9B
Q2 24
$510.4M
$2.6B
Q1 24
$465.3M
$3.4B
Total Debt
RRX
RRX
SF
SF
Q4 25
$4.8B
$617.4M
Q3 25
$617.2M
Q2 25
$617.0M
Q1 25
$616.8M
Q4 24
$5.5B
$616.6M
Q3 24
$5.7B
$616.4M
Q2 24
$5.8B
$1.1B
Q1 24
$6.2B
$1.1B
Stockholders' Equity
RRX
RRX
SF
SF
Q4 25
$6.8B
$6.0B
Q3 25
$6.8B
$5.8B
Q2 25
$6.7B
$5.6B
Q1 25
$6.4B
$5.5B
Q4 24
$6.3B
$5.7B
Q3 24
$6.5B
$5.6B
Q2 24
$6.4B
$5.4B
Q1 24
$6.3B
$5.3B
Total Assets
RRX
RRX
SF
SF
Q4 25
$13.9B
$41.3B
Q3 25
$13.9B
$41.7B
Q2 25
$13.9B
$39.9B
Q1 25
$14.0B
$40.4B
Q4 24
$14.0B
$39.9B
Q3 24
$14.6B
$38.9B
Q2 24
$14.6B
$37.8B
Q1 24
$15.1B
$38.3B
Debt / Equity
RRX
RRX
SF
SF
Q4 25
0.70×
0.10×
Q3 25
0.11×
Q2 25
0.11×
Q1 25
0.11×
Q4 24
0.88×
0.11×
Q3 24
0.87×
0.11×
Q2 24
0.91×
0.21×
Q1 24
1.00×
0.21×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RRX
RRX
SF
SF
Operating Cash FlowLast quarter
$167.8M
$382.4M
Free Cash FlowOCF − Capex
$140.6M
$369.0M
FCF MarginFCF / Revenue
9.2%
32.7%
Capex IntensityCapex / Revenue
1.8%
1.2%
Cash ConversionOCF / Net Profit
2.65×
1.45×
TTM Free Cash FlowTrailing 4 quarters
$893.1M
$1.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RRX
RRX
SF
SF
Q4 25
$167.8M
$382.4M
Q3 25
$197.5M
$338.3M
Q2 25
$523.2M
$607.5M
Q1 25
$102.3M
$-211.2M
Q4 24
$213.2M
$694.6M
Q3 24
$154.8M
$198.3M
Q2 24
$158.3M
$207.2M
Q1 24
$83.1M
$-609.7M
Free Cash Flow
RRX
RRX
SF
SF
Q4 25
$140.6M
$369.0M
Q3 25
$174.0M
$321.1M
Q2 25
$493.0M
$592.7M
Q1 25
$85.5M
$-227.8M
Q4 24
$183.9M
$677.2M
Q3 24
$125.5M
$185.6M
Q2 24
$125.9M
$173.3M
Q1 24
$64.6M
$-619.4M
FCF Margin
RRX
RRX
SF
SF
Q4 25
9.2%
32.7%
Q3 25
11.6%
33.4%
Q2 25
33.0%
70.6%
Q1 25
6.0%
-27.0%
Q4 24
12.6%
73.9%
Q3 24
8.5%
22.9%
Q2 24
8.1%
21.7%
Q1 24
4.2%
-80.6%
Capex Intensity
RRX
RRX
SF
SF
Q4 25
1.8%
1.2%
Q3 25
1.6%
1.8%
Q2 25
2.0%
1.8%
Q1 25
1.2%
2.0%
Q4 24
2.0%
1.9%
Q3 24
2.0%
1.6%
Q2 24
2.1%
4.2%
Q1 24
1.2%
1.3%
Cash Conversion
RRX
RRX
SF
SF
Q4 25
2.65×
1.45×
Q3 25
2.48×
1.60×
Q2 25
6.61×
3.92×
Q1 25
1.79×
-3.99×
Q4 24
5.17×
2.85×
Q3 24
2.13×
1.25×
Q2 24
2.53×
1.25×
Q1 24
4.20×
-3.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RRX
RRX

Other$470.6M31%
Industrial Powertrain Solutions Segment$441.8M29%
Automation And Motion Control Segment$327.7M22%
Power Efficiency Solutions Segment$283.2M19%

SF
SF

Segment breakdown not available.

Related Comparisons